Oscar Health Q3 EPS $(0.29) Beats $(0.51) Estimate, Sales $1.44B Beat $1.42B Estimate
Portfolio Pulse from Benzinga Newsdesk
Oscar Health (NYSE:OSCR) reported Q3 earnings per share of $(0.29), beating the analyst consensus estimate of $(0.51) by 43.14%. This is a 68.13% increase over losses from the same period last year. The company also reported quarterly sales of $1.44 billion, beating the analyst consensus estimate of $1.42 billion by 1.41%, a 47.18% increase over sales from the same period last year.
November 07, 2023 | 11:06 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Oscar Health's Q3 earnings and sales beat analyst estimates, indicating a strong financial performance.
Oscar Health reported better than expected Q3 earnings and sales, which indicates a strong financial performance. This could lead to increased investor confidence and potentially a short-term increase in the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100